
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Public health impact of UK COVID-19 booster vaccination programs during Omicron predominance
Diana Mendes, Ruth Chapman, Elena Aruffo, et al.
Expert Review of Vaccines (2022) Vol. 22, Iss. 1, pp. 90-103
Open Access | Times Cited: 11
Diana Mendes, Ruth Chapman, Elena Aruffo, et al.
Expert Review of Vaccines (2022) Vol. 22, Iss. 1, pp. 90-103
Open Access | Times Cited: 11
Showing 11 citing articles:
Key Considerations during the Transition from the Acute Phase of the COVID-19 Pandemic: A Narrative Review
Piotr Rzymski, Maria Pokorska‐Śpiewak, Teresa Jackowska, et al.
Vaccines (2023) Vol. 11, Iss. 9, pp. 1502-1502
Open Access | Times Cited: 20
Piotr Rzymski, Maria Pokorska‐Śpiewak, Teresa Jackowska, et al.
Vaccines (2023) Vol. 11, Iss. 9, pp. 1502-1502
Open Access | Times Cited: 20
Evaluating the COVID-19 vaccination program in Japan, 2021 using the counterfactual reproduction number
Taishi Kayano, Yura Ko, Kanako Otani, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 18
Taishi Kayano, Yura Ko, Kanako Otani, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 18
Impact of the COVID-19 Pandemic on Attitudes toward Vaccination: Representative Study of Polish Society
Tomasz Sobierajski, Piotr Rzymski, Monika Wanke-Rytt
Vaccines (2023) Vol. 11, Iss. 6, pp. 1069-1069
Open Access | Times Cited: 12
Tomasz Sobierajski, Piotr Rzymski, Monika Wanke-Rytt
Vaccines (2023) Vol. 11, Iss. 6, pp. 1069-1069
Open Access | Times Cited: 12
Cost-effectiveness analysis of COVID-19 booster vaccination with BNT162b2 in Japan
Mitsuhiro Nagano, Kazumasa Kamei, Hiroyuki Matsuda, et al.
Expert Review of Vaccines (2024) Vol. 23, Iss. 1, pp. 349-361
Open Access | Times Cited: 4
Mitsuhiro Nagano, Kazumasa Kamei, Hiroyuki Matsuda, et al.
Expert Review of Vaccines (2024) Vol. 23, Iss. 1, pp. 349-361
Open Access | Times Cited: 4
Ecological study of the association between the English national vaccination programme and area deprivation inequalities in COVID-19 mortality
Natalie Bennett, Clare Bambra, David R. Sinclair, et al.
BMJ Open (2025) Vol. 15, Iss. 1, pp. e085195-e085195
Open Access
Natalie Bennett, Clare Bambra, David R. Sinclair, et al.
BMJ Open (2025) Vol. 15, Iss. 1, pp. e085195-e085195
Open Access
Vaccine-Preventable Hospitalisations from Seasonal Respiratory Diseases: What Is Their True Value?
Margherita Neri, Simon Brassel, Hannah Schirrmacher, et al.
Vaccines (2023) Vol. 11, Iss. 5, pp. 945-945
Open Access | Times Cited: 4
Margherita Neri, Simon Brassel, Hannah Schirrmacher, et al.
Vaccines (2023) Vol. 11, Iss. 5, pp. 945-945
Open Access | Times Cited: 4
Public Health and Economic Impact of Periodic COVID-19 Vaccination with BNT162b2 for Old Adults and High-Risk Patients in an Illustrative Prefecture of Japan: A Budget Impact Analysis
Mitsuhiro Nagano, Kosuke Tanabe, Kazumasa Kamei, et al.
Infectious Diseases and Therapy (2024) Vol. 13, Iss. 10, pp. 2155-2177
Open Access | Times Cited: 1
Mitsuhiro Nagano, Kosuke Tanabe, Kazumasa Kamei, et al.
Infectious Diseases and Therapy (2024) Vol. 13, Iss. 10, pp. 2155-2177
Open Access | Times Cited: 1
Planning and adjusting the COVID-19 booster vaccination campaign to reduce disease burden
Laura Di Domenico, Yair Goldberg, Vittoria Colizza
Infectious Disease Modelling (2024) Vol. 10, Iss. 1, pp. 150-162
Open Access | Times Cited: 1
Laura Di Domenico, Yair Goldberg, Vittoria Colizza
Infectious Disease Modelling (2024) Vol. 10, Iss. 1, pp. 150-162
Open Access | Times Cited: 1
Assessing the COVID-19 vaccination program during the Omicron variant (B.1.1.529) epidemic in early 2022, Tokyo
Taishi Kayano, Hiroshi Nishiura
BMC Infectious Diseases (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 2
Taishi Kayano, Hiroshi Nishiura
BMC Infectious Diseases (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 2
Planning and adjusting the COVID-19 booster vaccination campaign to reduce disease burden
Laura Di Domenico, Yair Goldberg, Vittoria Colizza
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Laura Di Domenico, Yair Goldberg, Vittoria Colizza
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Modelling COVID-19 Vaccination in the UK: Impact of the Autumn 2022 and Spring 2023 Booster Campaigns
Diana Mendes, Sheeja Machira Krishnan, Esmé O’Brien, et al.
Infectious Diseases and Therapy (2024) Vol. 13, Iss. 5, pp. 1127-1146
Open Access
Diana Mendes, Sheeja Machira Krishnan, Esmé O’Brien, et al.
Infectious Diseases and Therapy (2024) Vol. 13, Iss. 5, pp. 1127-1146
Open Access